>US Stocks>Anika Therapeutics

Anika TherapeuticsHealthcare

$13.82+$3.69 (+36.39%)in 1 year

As on 13 Nov 2026 at 02:29NASDAQ

52 Week Low: $9.0152 Week High: $22.88

Anika Therapeutics Share Price Today

Anika Therapeutics opened lower at $13.80, compared with its previous close of $13.95. In the last trading session, the stock traded between $13.65 and $14.22. It showed a downward intraday trend.

Return calculator

You have invested

Time Period

An investment of $100 made 5 years ago in Anika Therapeutics is now worth

$ 36.17

Resulting in a loss of

$ 63.83 (63.83%)

Invest with $1

Note: Past profits do not guarantee future returns.

Analyst Overview

Rating from 2 Analysts

Buy

100%

Hold

Sell

Markets Today

Today's Change

$-0.13 (-0.96%)

Day High

$14.22

Day Low

$13.65

Day Open

$13.80

Prev Close

$13.95

Volume

78,499

1W Return

-32.14%

1M Return

-32.80%

3M Return

-35.09%

6M Return

-4.98%

1Y Return

36.39%

Fundamentals

Market Cap ($ Mn)

185

PE Ratio

PB Ratio

2.07

PEG Ratio

ROE

-6.74%

ROCE

-6.41%

EPS (TTM)

$-0.02

Investment Returns

1 Week

-32.14%

1 Month

-32.80%

3 Months

-35.09%

6 Months

-4.98%

9 Months

34.79%

Financials

Quarterly

All values in $ Mn

28.2

Jun 25

27.8

Sep 25

30.6

Dec 25

29.6

Mar 26

32.6

Jun 26

30.6

Sep 26

Updates

6Nov

Anika Therapeutics Q3FY26 Results: Adj. EPS $0.29 beats est, sales up 10%

Adjusted EPS of $0.29 beat consensus estimate of $0.06 by 383.33%. Quarterly sales rose 10.05% YoY to $30.594 million, beating estimates. Gross margin expanded to 62% from 56% in the prior year period. Full-year 2026 revenue guidance lower end raised to $119.588 million.

6 days ago

16Jul

Anika Therapeutics to issue Q2FY26 results on July 29

Anika Therapeutics, Inc. will announce its Q2FY26 financial results on July 29, 2026, followed by a conference call. The call will be accessible via phone and webcast, with materials available on the company's website.

4mo ago

Similar Stocks

Stock	LTP	Change %	Market Cap	PE
L Eli Lilly	$1,437.29	+0.35%	$13,52,123.38M	39.43
J Johnson & Johnson	$280.41	-0.13%	$6,75,033.80M	31.06
A Abbvie	$294.98	+0.37%	$5,21,411.37M	72.17
M Merck & Co	$147.18	-0.59%	$3,62,834.91M	117.74
N Novartis AG	$160.32	-1.80%	$3,26,222.34M	23.23
A Astrazeneca	$185.48	-0.69%	$2,87,691.54M	24.32
A AMGEN	$468.11	+0.62%	$2,53,205.85M	26.86
G Gilead Sciences	$169.73	-0.67%	$2,10,522.74M	-
P Pfizer	$29.45	+0.31%	$1,67,860.70M	36.79
N Novo Nordisk	$41.09	+0.96%	$1,39,300.36M	11.15
B Bristol Myers Squibb	$62.91	+0.18%	$1,28,593.45M	14.67
S Sanofi	$48.43	+0.41%	$1,16,984.89M	23.63